MicroBot Medical: Market Responds to New Patents; Scientific Advisory Board Appointments
Micro-robotic technology company, MicroBot Medical (Nasdaq: MBOT), has received two new patents for its LIBERTY Robotic System, the world’s first fully disposable robotic system for use in endovascular procedures.
MicroBot was issued a design patent allowance by the US Patent & Trademark Office, covering its robotic system’s remote controller’s unique interface design.
- In November 2022, MicroBot received a patent allowance issued by the Israeli Patent Office, complementing a corresponding application that was previously granted by the U.S. Patent and Trademark Office.
- MicroBot has secured five patents for the LIBERTY Robotic System since its launch in 2020.
- In October 2022, MicroBot added Thierry Jacques De Baère, MD, PhD, to its Scientific Advisory Board.
- De Baère is head of the Interventional Radiology Unit at Institut Gustave Roussy Cancer Center in Villejuif, France, the largest cancer center in Europe.
MicroBot Medical believes its LIBERTY Robotic System is well-positioned to change the landscape for endovascular procedures.